CRT-200.02 Jetstream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Artery: One-Year Results of the JET-ISR Study

Nicolas W Shammas,Nicholas Petruzzi,Steven Henao,Ehrin Armstrong,Thomas Shimshak,Subhash Banerjee,Faisal Latif,Britton Eaves,Thomas Brothers,Jaafer Golzar,Gail A Shammas,Susan Jones-Miller,Lori Christensen,W John Shammas

doi:10.1016/j.jcin.2020.01.195

CRT-200.02 Jetstream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Artery: One-Year Results of the JET-ISR Study

Nicolas W Shammas, Nicholas Petruzzi + Show 12 more

Open Access

https://doi.org/10.1016/j.jcin.2020.01.195

Copy DOI

Journal: JACC: Cardiovascular Interventions	Publication Date: Feb 1, 2020
License type: elsevier-specific: oa user license

Affiliation: Midwest Cardiovascular Research Foundation, New Mexico Heart Institute, AdventHealth Sebring, VA North Texas Health Care System, Advocate Christ Medical Center

#Target Lesion Revascularization #Excimer Laser + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Debulking of in-stent restenosis of femoropopliteal lesions was shown to provide superior freedom from target lesion revascularization (fTLR) with Excimer laser (EXCITE ISR) and the Jetstream device (IDE JET-ISR study) at 6 months. We report the 1-year TLR and patency rates of the JET-ISR study.

Full Text